Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Possibly the Next Evolution of GLP-1 Injections: If approved, CagriSema could become a key competitor in the obesity treatment market, potentially rivalling Eli Lillys tirzepatide more commonly known as Mounjaro or Zepbound, which achieved 21% weight loss in clinical trials
Heres what makes a difference: Age Younger skin has more collagen and snaps back more easily
Tirzepatide for treating type 2 diabetes | Guidance TA924
So far no side effects
Semaglutide works by: Enhancing insulin secretion in response to elevated blood glucose levels Suppressing glucagon release , which reduces glucose production by the liver Slowing gastric emptying , leading to prolonged feelings of fullness Acting on appetite centres in the brain , reducing hunger and food intake It is this combination of delayed gastric emptying and reduced appetite that contributes to weight loss in many patients
